MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-14-2025
Country |
 USA |
IPO year |
2017 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE AMERICAN |
Shares |
4.31 M |
Market Cap[1] |
$ 5.09 M |
EBITDA (LTM) |
$ -1.2 M |
P/E (LTM) |
-0.06 |
P/S (LTM) |
0.14 |
EPS (LTM) |
-11.26 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.7 | 50.0 % | $ 183 M | Nasdaq Global Select Market |  Canada |
 |
Cronos Group
CRON
|
$ 3.24 | 13.51 % | $ 1.69 B | Nasdaq Global Market | Canada |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Harrow Health
HROW
|
$ 47.18 | -7.67 % | $ 1.54 B | Nasdaq Global Market | USA |
 |
Aurora Cannabis
ACB
|
$ 5.36 | 17.8 % | $ 86.3 M | NYSE | Canada |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Emergent BioSolutions
EBS
|
$ 11.46 | -2.22 % | $ 587 M | NYSE,SPB | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Evoke Pharma
EVOK
|
$ 10.97 | 0.18 % | $ 36.7 M | Nasdaq Capital Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.38 | -0.05 % | $ 2.03 B | Nasdaq Global Select Market |  France |
 |
Pacira BioSciences
PCRX
|
$ 26.28 | 2.14 % | $ 1.22 B | Nasdaq Global Select Market,SPB | USA |
 |
Evolus
EOLS
|
$ 6.99 | 1.09 % | $ 433 M | Nasdaq Global Market | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
China Pharma Holdings
CPHI
|
$ 1.67 | 11.33 % | $ 29.2 M | NYSE American |  China |
 |
Perrigo Company plc
PRGO
|
$ 13.13 | -2.23 % | $ 1.8 B | NYSE | USA |
 |
ProPhase Labs
PRPH
|
$ 0.12 | -15.26 % | $ 1.9 M | Nasdaq Capital Market | USA |
 |
Rockwell Medical
RMTI
|
$ 0.93 | -2.37 % | $ 21.7 M | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Bausch Health Companies
BHC
|
$ 6.95 | -0.93 % | $ 2.54 B | NYSE | Canada |
 |
SCYNEXIS
SCYX
|
$ 0.64 | -0.02 % | $ 30.6 M | Nasdaq Global Select Market | USA |
 |
Assertio Holdings
ASRT
|
$ 0.77 | -1.79 % | $ 54.7 M | Nasdaq Capital Market | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.88 | 14.72 % | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Solid Biosciences
SLDB
|
$ 5.85 | -0.34 % | $ 239 M | Nasdaq Global Select Market,SPB | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Organogenesis Holdings
ORGO
|
$ 4.83 | 1.15 % | $ 636 M | Nasdaq Capital Market | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.59 | -3.37 % | $ 4.46 M | Nasdaq Capital Market | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 2.61 | 4.99 % | $ 36.7 M | Nasdaq Global Select Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.12 | -1.67 % | $ 124 M | Nasdaq Global Select Market,SPB | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Sundial Growers
SNDL
|
$ 2.19 | 24.01 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Veru
VERU
|
$ 2.45 | -4.3 % | $ 330 M | Nasdaq Capital Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Tilray
TLRY
|
$ 11.86 | 40.68 % | $ 7.33 B | Nasdaq Global Select Market | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
TherapeuticsMD
TXMD
|
$ 1.79 | -2.72 % | $ 18.7 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.